Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $85M

Overview

Accelus is an emerging player in the spine surgery device sector, formed to advance minimally invasive surgical (MIS) techniques. The company leverages a portfolio of integrated technologies, including implants, instruments, and enabling software, targeting a significant global market for spinal disorders. As a private entity, it operates in a highly competitive landscape dominated by large, established medtech firms, with its success hinging on clinical adoption, execution, and potential future funding.

Spine SurgeryOrthopedics

Technology Platform

Integrated platform of minimally invasive spinal implants, specialized surgical instruments, and enabling software for procedural planning and execution.

Funding History

3
Total raised:$85M
Series B$50M
Series A$15M
Series A$20M

Opportunities

The global shift towards minimally invasive spine surgery and outpatient procedures in Ambulatory Surgery Centers (ASCs) creates strong demand for integrated technologies like those developed by Accelus.
The large and aging population ensures a growing addressable market for spinal fusion and stabilization procedures.

Risk Factors

Intense competition from large, well-capitalized medical device companies with entrenched surgeon relationships poses a major commercial barrier.
As a private company, reliance on investor funding and the risk of running out of capital before achieving profitability is a significant financial risk.

Competitive Landscape

The spine surgery market is dominated by large players like Medtronic, Stryker, Johnson & Johnson (DePuy Synthes), and Globus Medical, along with strong pure-play competitors like NuVasive and SeaSpine. Accelus must differentiate on technology, price, surgeon training, and service to compete effectively in this crowded field.